Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2026 05:37 ET | Source: Research and Markets

APT-1011 Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "APT-1011 Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. The APT-1011 market report provides...
May 15, 2026 05:35 ET | Source: Research and Markets

Cendakimab Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Cendakimab Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. This report offers insights into...
May 15, 2026 05:33 ET | Source: Research and Markets

Tradipitant Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Tradipitant Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. The report offers insights into...
January 23, 2026 06:23 ET | Source: Research and Markets

In Silico Clinical Trials Market Research Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "In Silico Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
March 24, 2025 05:02 ET | Source: Research and Markets

Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2024-2029: 25 Therapies Currently in Trial - Many will Penetrate the Market in the Imminent 5-7 Years

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029" report has been added to ResearchAndMarkets.com's offering. Antecedently,...
October 15, 2024 10:40 ET | Source: Research and Markets

Final Days to Register: Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors Training Course (ONLINE EVENT: January 29-31, 2025 & ON-DEMAND)

Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors - Broadening your Knowledge Training Course" conference has been added to ...
August 12, 2024 04:52 ET | Source: Research and Markets

CRISPR Cas9 Market and Clinical Trials Report to 2029: CRISPR-Cas9 Therapy Clinical Trials By Company, County, Indication & Phase

Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029" report has been added to ResearchAndMarkets.com's offering. The global landscape...
January 29, 2024 12:18 ET | Source: Research and Markets

Emerging ONC201 Drug Set to Transform Glioblastoma Multiforme Treatment Landscape: Drug Insights and Market Forecasts to 2032

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "ONC201 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
January 24, 2024 09:14 ET | Source: Research and Markets

Otenaproxesul for Osteoarthritis: A Novel NSAID that Releases Hydrogen Sulfide - Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Otenaproxesul Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
January 24, 2024 09:09 ET | Source: Research and Markets

ITI-1000 (pp65 DC vaccine) for Glioblastoma Multiforme (GBM): Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032 - Focus on US, Germany, France, Italy, Spain, UK, and Japan

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "ITI-1000 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...